Phase 1 Metastatic NSCLC Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC

Non-small Cell Lung CancerAdvanced/Metastatic NSCLC

Beijing Biotech48 enrolled1 locationNCT07467863

Recruiting

Phase 1

A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)

Locally Advanced or Metastatic NSCLC

Jiangsu Hansoh Pharmaceutical Co., Ltd.230 enrolled1 locationNCT06461156

Recruiting

Phase 1Phase 2

Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)

Advanced or Metastatic NSCLC

Jiangsu Hansoh Pharmaceutical Co., Ltd.354 enrolled1 locationNCT05435248